CORONA, SILVIA

CORONA, SILVIA  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Settore MED/06 - Oncologia Medica  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.114 secondi).
Titolo Data di pubblicazione Autori File
Abemaciclib: A CDK4/6 inhibitor for the treatment of HR+/HEeR2- advanced breast cancer 1-gen-2018 Corona, Silvia PaolaGenerali, Daniele
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 1-gen-2018 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR 1-gen-2018 Generali, DanieleCorona, Silvia Paola +
CDK4/6 inhibitors in HER2-positive breast cancer 1-gen-2017 Corona, Silvia PaolaRavelli, AngeloGENERALI, DANIELE +
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer 1-gen-2017 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Corticosteroid switch after progression on abiraterone acetate plus prednisone 1-gen-2020 Roviello G.Sobhani N.Corona S. +
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? 1-gen-2017 Corona, Silvia PaolaRoviello, GiandomenicoGenerali, Daniele +
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 1-gen-2017 SOBHANI, NAVIDCorona, Silvia PZANCONATI, FABRIZIOGENERALI, DANIELE
Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials 1-gen-2019 Corona S.Roviello G.Bortul M.Zanconati F.Giudici F.Generali D. +
Evaluation of circulating cell-free DNA and its integrity as a potential predictive biomarker of breast cancer onset: A pilot study 1-gen-2020 Scaggiante B.Giudici F.Zanconati F.Bottin C.Corona S.Cappelletti M.Generali D.Bortul M. +
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 1-gen-2017 Corona, Silvia PaolaGenerali, DanieleRoviello, Giandomenico +
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 1-gen-2020 Roviello G.Corona S. +
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study 1-gen-2020 Corona, SGiudici, FBernocchi, OGenerali, D +
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies before and after Chemotherapy 1-gen-2019 Roviello G.Corona S. +
Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer? 1-gen-2019 Roviello G.Corona S. +
Isolated testicular metastasis from prostate cancer 1-gen-2017 Generali, DanieleCorona, Silvia PaolaRoviello, Giandomenico +
Lenvatinib for the treatment of renal cell carcinoma 1-gen-2018 Roviello G.Corona S.Generali D.Ianza A.Sobhani N. +
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis 1-gen-2017 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele